The U.S. Food and Drug Administration on Tuesday classified the recall of Medtronic's embolization device as "most serious", ...

Medtronic (MDT) stock turned lower as the FDA announced a most serious type of recall involving its Pipeline Vantage 027 ...

In a notice posted to the agency’s website, the FDA noted that on January 30, 2025, Medtronic (MDT) Neurovascular sent all affected customers ...

BD, Medtronic and Abbott were among the top 10 medical device manufacturers with the highest number of late reports, the ...

The CEO was also bullish on the future of renal denervation. Medtronic and Recor Medical are the only companies to secure FDA approval for renal denervation products, and the Centers for Medicare and ...

The U.S. FDA and HHS announced on Tuesday a set of actions and initiatives focused on infant formula to ensure the ongoing quality, safety, nutritional adequacy and resilience of the domestic infant ...

For the one million people diagnosed with Parkinson's disease in the United States, Medtronic plc (NYSE:MDT), a global leader in healthcare technology, proudly announces U.S. Food and Drug ...

Nearly 10% of postmarket device safety reports in MAUDE were submitted over 6 months after the safety event occurred.

Medtronic is nearing a U.S. launch for its Hugo surgical robot more than three years after receiving approval to release the soft tissue system in Europe. CEO Geoff Martha told investors Tuesday ...

Medtronic’s Percept PC neurostimulator with BrainSense technology [Image courtesy of Medtronic] Medtronic (NYSE: MDT) + announced today that the FDA approved its BrainSense adaptive deep brain ...

Medtronic VP Jason Fontana offered advice for other device developers who might one day be looking for their own NCA.